跳至主要内容
临床试验/NCT01431820
NCT01431820已完成2 期

Safety and Efficacy of Luliconazole Solution, 10% With Two Dosing Regimens in Distal Subungual Onychomycosis of the Toenails: A Randomized, Double-Blind, Vehicle-Controlled, Phase 2B/3 Study

Topica Pharmaceuticals0 个研究点目标入组 334 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
334
主要终点
The proportion of subjects who achieve complete cure of the target great toenail

研究概览

简要总结

The purpose of this study is to determine the safety and efficacy of a topical antifungal formulation, Luliconazole Solution, 10%, in the treatment of adults with onychomycosis of the toenails.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects of either gender, any race and between the ages of 18 and 70 inclusive
  • Subjects with a clinical diagnosis with culture confirmation of distal subungual onychomycosis (DSO) - Subjects must be free of any disease that in the Investigator's opinion might interfere with the study evaluations or jeopardize the subject's safety

排除标准

  • Subjects with a history of intolerance or hypersensitivity to imidazole compounds or the inactive components of the solution
  • Subjects who are currently participating or have recently participated in another investigational medication or device study

研究组 & 干预措施

Luliconazole Solution, 10% Regimen 1

Experimental

干预措施: Luliconazole Solution, 10% (Drug)

Luliconazole Solution, 10% Regimen 2

Experimental

干预措施: Luliconazole Solution, 10% (Drug)

Vehicle Solution Regimen 1

Placebo Comparator

干预措施: Vehicle Solution (Drug)

Vehicle Solution Regimen 2

Placebo Comparator

干预措施: Vehicle Solution (Drug)

结局指标

主要结局

The proportion of subjects who achieve complete cure of the target great toenail

时间窗: Week 52

次要结局

未报告次要终点

研究者

发起方
Topica Pharmaceuticals
申办方类型
Industry
责任方
Sponsor

相似试验